Form 8-K - Current report:
SEC Accession No. 0001493152-18-017046
Filing Date
2018-12-05
Accepted
2018-12-04 17:40:51
Documents
2
Period of Report
2018-11-30
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 27346
2 ex4-1.htm EX-4.1 83243
  Complete submission text file 0001493152-18-017046.txt   111780
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 000-51476 | Film No.: 181217982
SIC: 2834 Pharmaceutical Preparations